Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

National Drug Code

Is NDC 68462-0380-01 recalled?

Theophylline · 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68462-380-01)

Yes — this exact package was recalled

2 FDA recalls name the code 68462-0380-01 directly. A recall still applies to particular lot numbers — compare the lot on your package with the FDA notice below, and talk to your pharmacist before stopping a prescribed medication.

1 of these recalls is still ongoing.

Active ingredient
Theophylline
Strength
THEOPHYLLINE ANHYDROUS 400 mg/1
Form
Tablet, Extended Release · Oral
Labeler
Glenmark Pharmaceuticals Inc., USA
Type
Human Prescription Drug
Product code
68462-0380

Recalls naming this package

Class II · Moderate risk

Theophylline extended-release tablets 400mg

Failed Dissolution Specifications: Failure results (above) were reported for the Dissolution (by UV) test for commercial annual stability at the long-term shelf life stability interval, wherein the dissolution results do not comply with L3 stage dissolution criteria.

Ongoing Dissolution failure Glenmark Pharmaceuticals Inc., USA NDC 68462-380-01 D-0583-2025
Class II · Moderate risk

Theophylline

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 68462-380-01 D-0485-2021

Where to find this code. The NDC is printed on the pharmacy label and on the manufacturer's carton, usually as three groups of digits after “NDC”. The last group is the package size — two bottles of the same medicine can differ only in that group, and a recall may cover one but not the other.

Other recalled products from this labeler